Company Profile

Involving some experienced players and though indicated as three years since founding, G5 Biological and the assembled team indicated have an almost non-existent online presence. The proposed technology appears to involve development of an intraoperative method to modify biological grafts to improve clinical performance with indication that the players involved have years of experience developing these type of nanomaterial-tissue bionanocomposites. Important work that we look forward to/hope to follow-up